All In Biotech

Free tool

FAERS Monitor: Micardis Hct

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021162 or its brand name (Micardis Hct, Hydrochlorothiazide, Telmisartan). Reports on generic versions are filed under their own applications.

Reports

2,358

Serious

1,474

63% of reports

Hospitalization

760

Death reported

145

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dizziness152
  • drug ineffective120
  • nausea118
  • fatigue112
  • headache111
  • blood pressure increased105
  • diarrhoea96
  • dyspnoea93
  • hypotension84
  • hypertension83
  • fall81
  • vomiting79
  • asthenia75
  • arthralgia72
  • pain71

Reports by year received

View as table
YearReports
200448
200558
200680
2007132
2008189
2009186
2010243
2011245
2012218
2013104
2014100
201597
2016101
201780
201888
201976
202066
202151
202230
202339
202434
202563
202630

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,801 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure increasedSignal1056.15.1449
hypotensionSignal843.73.0167
hypertensionSignal833.52.8147
dizzinessSignal1522.72.3167
fallSignal812.21.851
asthenia751.81.425
headache1111.61.324
arthralgia721.51.214
vomiting791.51.213
dyspnoea931.51.214
nausea1181.31.110
diarrhoea961.31.18
fatigue1121.31.17
pain711.00.80
drug ineffective1200.80.75

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.